Study of Growing Biofilm by an Antiplaque Mouthrinse

Dental Plaque Clinical Trial

— Bain de bouche  

Official title:

A Double Blind Randomized, Placebo-controlled, Cross-over Trial to Evaluate the Efficiency of a Mouthrinse, Containing Red Grape Seed Extract and nicométhanol Fluorhydrate, in the Control of Dental Plaque Deposit in a 4-days Plaque Regrowth Model

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00838266
• Other study ID #: CHUBX 2008/05
• Status: Completed
• Phase: Phase 3
• First received: February 5, 2009
• Last updated: September 22, 2009
• Start date: February 2009
• Est. completion date: March 2009

Study information

• Verified date: September 2009
• Source: University Hospital, Bordeaux
• Contact: n/a
• Is FDA regulated: No
• Health authority: France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
• Study type: Interventional

Clinical Trial Summary

The objective of this study is to evaluate the efficiency of a new mouthrinse on dental plaque deposits.

The study is carried out on 50 volunteers that are asked to use the mouthrinse without any other oral hygiene measure, during 4 days. It is a double bind, cross-over, randomized design: the same subjects test the active product and the placebo.

Description:

The prevention of oral diseases is mainly targeted at the control of dental plaque. While tooth brushing is an effective method to remove plaque mechanically, it is not always sufficient and chemical antiplaque agents could be helpful. Some of them are used for their antibacterial action, the gold standard being chlorhexidine. Despite the great benefit of this bactericidal approach, the search continues for active ingredients that could prevent dental plaque formation without affecting the biological equilibrium within the oral cavity.

The aim of this study is to evaluate the efficiency of a mouthrinse, containing red grape seed extract and nicométhanol fluorhydrate, in the control of dental plaque deposit in a 4-days plaque regrowth model.

The study is a double blind randomized cross-over design, involving 50 healthy volunteers. During the treatment periods (4 days) no oral hygiene, measures excepting rinsing with the allocated product (active/non active) are permitted.

On day 1, the subjects receive professional prophylaxis. The mouthrinse is used pure, three times per day, after each meal. On day 5, subjects will be scored for disclosed plaque using the Quigley Hein index (modified by Turesky).

After a 2 weeks wash-out period, the subject receives the other product (active/non active) and uses it as in the first period.

On day 5, subjects will be scored again for disclosed plaque

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: March 2009
• Est. primary completion date: March 2009
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Healthy volunteer

• without caries

• with at least 20 natural teeth excluding third molars

• Women using contraceptives for at least twelve weeks and while on study

• Protected by French social security system

• Written informed consent

Exclusion Criteria:

• Pregnancy or breast feeding

• Volunteers with partial denture or orthodontic appliance

• Person protected by the law who

• Person unable to give their consent to participate to the study.

• Under aged

• Current participation in another clinical trial

• Oral pathologies

• Systemic diseases

• Volunteers allergic to of the componentst of the tested products

• Volunteers with hyposalivation or xerostomia

• Treatment with antibiotics o intestinal antiseptics within 3 month before inclusion

• Treatment with oral antiseptics within 1 month before inclusion

• Alcoholic consumption more than 20 g/day (or 2 glasses)

• Heavy smokers

• Volunteers drinking a lot of tea or coffee

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Dental Plaque

Intervention

Drug:
• mouthrinse (Grape Seed Extract + nicomethanol fluorhydrate)
Antiplaque mouthrinse containing active component three times a day, during 1 minute, for 4 days

Other:
• mouthrinse containing non-active component
Antiplaque mouthrinse containing non-active component three times a day, during 1 minute, for 4 days

Locations

Country	Name	City	State
France	CHU de Bordeaux - Hôpital ST André - 1 rue Jean Burguet	Bordeaux

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Bordeaux

Country where clinical trial is conducted

France, 

References & Publications (4)

Addy M. Evaluation of clinical trials of agents and procedures to prevent caries and periodontal disease: choosing products and recommending procedures. Int Dent J. 1995 Jun;45(3):185-96. Review. — View Citation

Furiga A, Lonvaud-Funel A, Dorignac G, Badet C. In vitro anti-bacterial and anti-adherence effects of natural polyphenolic compounds on oral bacteria. J Appl Microbiol. 2008 Nov;105(5):1470-6. doi: 10.1111/j.1365-2672.2008.03882.x. Epub 2008 Sep 13. — View Citation

Guidelines for acceptance of chemotherapeutic products for the control of supragingival dental plaque and gingivitis. Council on Dental Therapeutics. J Am Dent Assoc. 1986 Apr;112(4):529-32. — View Citation

Yates RJ, Shearer BH, Morgan R, Addy M. A modification to the experimental gingivitis protocol to compare the antiplaque properties of two toothpastes. J Clin Periodontol. 2003 Feb;30(2):119-24. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Plaque index of Quickley-Hein modified by Tureski. Plaque deposits are scored on all natural teeth (except third molars) after staining.		Measures are done on days 5 of the two plaque growth periods	No
Secondary	Product tolerance		on days 5 of the two plaque growth periods	Yes
Secondary	Product acceptability (oral sensation)		on days 5 of the two plaque growth periods	Yes